Unicycive Therapeutics Stock Forecast - Market Facilitation Index

UNCY Stock  USD 1.14  0.08  6.56%   
Unicycive Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Unicycive Therapeutics stock prices and determine the direction of Unicycive Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Unicycive Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Unicycive Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Unicycive Therapeutics' systematic risk associated with finding meaningful patterns of Unicycive Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Unicycive Therapeutics to cross-verify your projections.
For more information on how to buy Unicycive Stock please use our How to Invest in Unicycive Therapeutics guide.
  
Payables Turnover is likely to rise to 0.36 in 2024, whereas Fixed Asset Turnover is likely to drop 0.81 in 2024. . Common Stock Shares Outstanding is likely to drop to about 18.7 M in 2024. Net Loss is likely to rise to about (8.6 M) in 2024.
Unicycive Therapeutics has current Market Facilitation Index of 0.14.
Most investors in Unicycive Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Unicycive Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Unicycive Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.
Check Unicycive Therapeutics VolatilityBacktest Unicycive TherapeuticsInformation Ratio  

Unicycive Therapeutics Trading Date Momentum

On April 16 2024 Unicycive Therapeutics was traded for  1.14  at the closing time. The top price for the day was 1.24  and the lowest listed price was  1.10 . There was no trading activity during the period 0.0. Lack of trading volume on April 16, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 7.02% .
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Unicycive Therapeutics to competition

Other Forecasting Options for Unicycive Therapeutics

For every potential investor in Unicycive, whether a beginner or expert, Unicycive Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Unicycive Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Unicycive. Basic forecasting techniques help filter out the noise by identifying Unicycive Therapeutics' price trends.

Unicycive Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Unicycive Therapeutics stock to make a market-neutral strategy. Peer analysis of Unicycive Therapeutics could also be used in its relative valuation, which is a method of valuing Unicycive Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Unicycive Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Unicycive Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Unicycive Therapeutics' current price.

Unicycive Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Unicycive Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Unicycive Therapeutics shares will generate the highest return on investment. By undertsting and applying Unicycive Therapeutics stock market strength indicators, traders can identify Unicycive Therapeutics entry and exit signals to maximize returns.

Unicycive Therapeutics Risk Indicators

The analysis of Unicycive Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Unicycive Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting unicycive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Unicycive Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Unicycive Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unicycive Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unicycive Therapeutics Stock:
Check out Historical Fundamental Analysis of Unicycive Therapeutics to cross-verify your projections.
For more information on how to buy Unicycive Stock please use our How to Invest in Unicycive Therapeutics guide.
Note that the Unicycive Therapeutics information on this page should be used as a complementary analysis to other Unicycive Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Unicycive Stock analysis

When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Unicycive Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Unicycive Therapeutics. If investors know Unicycive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Unicycive Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.28)
Revenue Per Share
0.028
Return On Assets
(1.53)
Return On Equity
(6.97)
The market value of Unicycive Therapeutics is measured differently than its book value, which is the value of Unicycive that is recorded on the company's balance sheet. Investors also form their own opinion of Unicycive Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Unicycive Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Unicycive Therapeutics' market value can be influenced by many factors that don't directly affect Unicycive Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Unicycive Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Unicycive Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unicycive Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.